Revenue (Quarterly) Chart

View Revenue (Quarterly) for KANKF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 1.400B
March 31, 2026 1.360B
December 31, 2025 1.304B
September 30, 2025 1.348B
June 30, 2025 1.374B
March 31, 2025 1.340B
December 31, 2024 1.359B
September 30, 2024 1.324B
June 30, 2024 1.273B
March 31, 2024 1.331B
December 31, 2023 1.316B
September 30, 2023 1.296B
June 30, 2023 1.329B
March 31, 2023 1.425B
December 31, 2022 1.319B
September 30, 2022 1.358B
June 30, 2022 1.484B
March 31, 2022 1.572B
December 31, 2021 1.569B
September 30, 2021 1.509B
June 30, 2021 1.500B
March 31, 2021 1.470B
December 31, 2020 1.481B
September 30, 2020 1.320B
June 30, 2020 1.178B
Date Value
March 31, 2020 1.368B
December 31, 2019 1.404B
September 30, 2019 1.407B
June 30, 2019 1.354B
March 31, 2019 1.393B
December 31, 2018 1.433B
September 30, 2018 1.380B
June 30, 2018 1.395B
March 31, 2018 1.387B
December 31, 2017 1.361B
September 30, 2017 1.333B
June 30, 2017 1.298B
March 31, 2017 1.234B
December 31, 2016 1.259B
September 30, 2016 1.310B
June 30, 2016 1.261B
March 31, 2016 1.198B
December 31, 2015 1.131B
September 30, 2015 1.150B
June 30, 2015 1.148B
March 31, 2015 1.160B
December 31, 2014 1.229B
September 30, 2014 1.322B
June 30, 2014 1.331B
March 31, 2014 1.302B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Nitto Denko Corp. 1.705B
Shin-Etsu Chemical Co., Ltd. 4.157B
Kuraray Co., Ltd. 1.444B
LINTEC Corp. 521.97M
Daicel Corp. 956.26M